| abstract |
The subject of the invention is a medicament comprising, as active principle, an effective amount of at least one oligosaccharide substance suitable for modulate the apoptosis disorders and possibly including, on at minus some of its unit patterns, at least one group substituent comprising the sulfate, methyl and acetyl groups, the substance being chosen from the group comprising oligosaccharides derived by the enzymatic or chemical of polymers from the group comprising .beta. 1-3 glucans possibly having ramifications .beta. 1-6, and oligosaccarides derived enzymatically or chemically from galactans sulfates, especially carrageenans, agars and porphyranes. |